Tribune News Service
New Delhi, October 23
India’s Covid graph continues to decline with the active cases falling below seven lakh for the first time after two months, 63 days to be precise.
Meanwhile, the DCGI has approved the ICMR-Bharat Biotech's Covaxin candidate for phase 3 human trial, considered conclusive for establishing vaccine’s efficacy and safety. The Central Government is making a national Covid immunisation plan under which it will directly procure vaccines for states. Priority groups, such as health workers and those with co-morbidities, will get vaccine for free.
Join Whatsapp Channel of The Tribune for latest updates.
4
6
9